CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
Effective Trade-off between Response and Toxicity by Using a Combination of Ac-225 and Lu-177 Labelled PSMA-617 for Progressive End-Stage Metastatic Prostate Cancer
DOI 10.1055/s-0039-1683560
Bibliografische Angaben
Nachweis in CareLit
Autor:innenHR Kulkarni, J Zhang, T Langbein, A Singh, C Schuchardt, C Lehmann, RP Baum
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe02/2019
Jahrgang / SeitenJg. 58
Kernaussage aus der Literatur
Abstract-Vorschau
Effective Trade-off between Response and Toxicity by Using a Combination of Ac-225 and Lu-177 Labelled PSMA-617 for Progressive End-Stage Metastatic Prostate Cancer
Zitieren
Zitierempfehlung
HR Kulkarni, J Zhang, T Langbein, A Singh, C Schuchardt, C Lehmann, RP Baum (2019) Effective Trade-off between Response and Toxicity by Using a Combination of Ac-225 and Lu-177 Labelled PSMA-617 for Progressive End-Stage Metastatic Prostate Cancer. Nuklearmedizin - NuclearMedicine, 58 (02). https://doi.org/10.1055/s-0039-1683560
Mit CareLit weiterarbeiten